BRENICE DUROSEAU: Open Payments
NPI 1730654815 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 8 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $678 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $684 |
| ViiV Healthcare Company | 2 | $171 |
Products named: Yeztugo, Sunlenca, Biktarvy.
Industry payments across MD — which companies pay providers there.
